Latest Cancer News

Seattle Genetics Announces FDA Approval of ADCETRIS® (Brentuximab Vedotin) for Primary Cutaneous Anaplastic Large Cell Lymphoma (pcALCL) and CD30-Expressing Mycosis Fungoides (MF) (11-15-2017)
-MF and pcALCL Represent the Most Common Subtypes of Cutaneous T-Cell Lymphoma (CTCL)- -FDA Approval Based on Clinical Trial Results from the Phase 3 ALCANZA and Phase 2 Investigator-Sponsored Studies... Continue Reading

Kisqali® Improves Outcomes for Premenopausal Women with HR+/HER2- Advanced Breast Cancer (11-14-2017)
Premenopausal breast cancer is a biologically distinct and more aggressive disease than postmenopausal breast cancer and is the leading cause of cancer death in women 20-59 years old.1,2 ,3 Historically... Continue Reading

Alcensa Precision Medicine Approved for (ALK) Positive Non-Small Cell Lung Cancer (11-13-2017)
The Food and Drug Administration granted regular approval to Alcensa (alectinib), for treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC),... Continue Reading

More Cancer News

Locations

Bon Secours Cancer Institute

Richmond Radiation Oncology Center
6605 West Broad St.
Suite G201
Richmond, VA 23230
p: (804) 266-7762

St Mary’s Hospital
Radiation Oncology Dept
5801 Bremo Road
Richmond, VA 23226
p: (804) 281-8350

St Francis Medical Center
Radiation Oncology Dept
14051 St. Francis Bvld.
Midlothian, VA 23114
p: (804) 594-4900

Virginia Urology

Stony Point Office & Surgery Center
9105 Stony Point Drive
Richmond, VA 23235
p: (804) 330 9105